These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 37711117)
1. Portuguese Neonatal Screening Programme: A Retrospective Cohort Study of 18 Years of MS/MS. Gonçalves MM; Marcão A; Sousa C; Nogueira C; Ferreira F; Fonseca H; Rocha H; Vilarinho L Endocr Metab Immune Disord Drug Targets; 2023 Sep; ():. PubMed ID: 37711117 [TBL] [Abstract][Full Text] [Related]
2. Portuguese Neonatal Screening Program: A Cohort Study of 18 Years Using MS/MS. Gonçalves MM; Marcão A; Sousa C; Nogueira C; Fonseca H; Rocha H; Vilarinho L Int J Neonatal Screen; 2024 Mar; 10(1):. PubMed ID: 38535129 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive multiplex PCR based exome-sequencing assay for rapid bloodspot confirmation of inborn errors of metabolism. Wang W; Yang J; Xue J; Mu W; Zhang X; Wu W; Xu M; Gong Y; Liu Y; Zhang Y; Xie X; Gu W; Bai J; Cram DS BMC Med Genet; 2019 Jan; 20(1):3. PubMed ID: 30612563 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and therapeutic monitoring of inborn errors of metabolism in 100,077 newborns from Jining city in China. Yang CJ; Wei N; Li M; Xie K; Li JQ; Huang CG; Xiao YS; Liu WH; Chen XG BMC Pediatr; 2018 Mar; 18(1):110. PubMed ID: 29534692 [TBL] [Abstract][Full Text] [Related]
5. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review. Pandor A; Eastham J; Beverley C; Chilcott J; Paisley S Health Technol Assess; 2004 Mar; 8(12):iii, 1-121. PubMed ID: 14982654 [TBL] [Abstract][Full Text] [Related]
6. Four years of expanded newborn screening in Portugal with tandem mass spectrometry. Vilarinho L; Rocha H; Sousa C; Marcão A; Fonseca H; Bogas M; Osório RV J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S133-8. PubMed ID: 20177789 [TBL] [Abstract][Full Text] [Related]
7. Incidence and genetic variants of inborn errors of metabolism identified through newborn screening: A 7-year study in eastern coastal areas of China. Men S; Liu S; Zheng Q; Yang S; Mao H; Wang Z; Gu Y; Tang X; Wang L Mol Genet Genomic Med; 2023 Jun; 11(6):e2152. PubMed ID: 36787440 [TBL] [Abstract][Full Text] [Related]
9. Sequencing from dried blood spots in infants with "false positive" newborn screen for MCAD deficiency. McCandless SE; Chandrasekar R; Linard S; Kikano S; Rice L Mol Genet Metab; 2013 Jan; 108(1):51-5. PubMed ID: 23151387 [TBL] [Abstract][Full Text] [Related]
10. A new chemical diagnostic method for inborn errors of metabolism by mass spectrometry-rapid, practical, and simultaneous urinary metabolites analysis. Matsumoto I; Kuhara T Mass Spectrom Rev; 1996; 15(1):43-57. PubMed ID: 27082169 [TBL] [Abstract][Full Text] [Related]
11. Inborn errors of metabolism and expanded newborn screening: review and update. Mak CM; Lee HC; Chan AY; Lam CW Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058 [TBL] [Abstract][Full Text] [Related]
12. Detection of inborn errors of metabolism using GC-MS: over 3 years of experience in southern China. Jiang M; Liu L; Mei H; Li X; Cheng J; Cai Y J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):375-80. PubMed ID: 25781538 [TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing as a follow-up test in an expanded newborn screening programme. Smon A; Repic Lampret B; Groselj U; Zerjav Tansek M; Kovac J; Perko D; Bertok S; Battelino T; Trebusak Podkrajsek K Clin Biochem; 2018 Feb; 52():48-55. PubMed ID: 29111448 [TBL] [Abstract][Full Text] [Related]
14. Medium-chain acyl-CoA dehydrogenase deficiency: Two novel ACADM mutations identified in a retrospective screening. Smon A; Groselj U; Debeljak M; Zerjav Tansek M; Bertok S; Avbelj Stefanija M; Trebusak Podkrajsek K; Battelino T; Repic Lampret B J Int Med Res; 2018 Apr; 46(4):1339-1348. PubMed ID: 29350094 [TBL] [Abstract][Full Text] [Related]
15. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand. Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410 [TBL] [Abstract][Full Text] [Related]
16. A retrospective analysis of MS/MS screening for IEM in high-risk areas. He X; Kuang J; Lai J; Huang J; Wang Y; Lan G; Xie Y; Shi X BMC Med Genomics; 2023 Mar; 16(1):57. PubMed ID: 36927542 [TBL] [Abstract][Full Text] [Related]
17. Differences between acylcarnitine profiles in plasma and bloodspots. de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448 [TBL] [Abstract][Full Text] [Related]
18. New Advances for Newborn Screening of Inborn Errors of Metabolism by Capillary Electrophoresis-Mass Spectrometry (CE-MS). Shanmuganathan M; Britz-McKibbin P Methods Mol Biol; 2019; 1972():139-163. PubMed ID: 30847789 [TBL] [Abstract][Full Text] [Related]
19. Neonatal screening of inborn errors of metabolism using tandem mass spectrometry: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2003; 3(3):1-36. PubMed ID: 23074443 [TBL] [Abstract][Full Text] [Related]
20. Pilot study of gas chromatographic-mass spectrometric screening of newborn urine for inborn errors of metabolism after treatment with urease. Kuhara T; Shinka T; Inoue Y; Ohse M; Zhen-wei X; Yoshida I; Inokuchi T; Yamaguchi S; Takayanagi M; Matsumoto I J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(1):141-7. PubMed ID: 10492000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]